William L. Cornog
William L. Cornog's purchase track record
How the stock did after each of William L. Cornog's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/6/2026 | BV | $562K | pending | pending | — |
| 5/18/2026 | AZTA | $164K | +106.8% | pending | — |
| 2/6/2026 | BV | $67K | -4.3% | -15.5% | +11.9% |
| 12/2/2025 | BV | $128K | +5.6% | -6.1% | +11.4% |
| 2/21/2025 | BV | $135K | +19.0% | +10.8% | +7.5% |
| 11/18/2024 | AZTA | $495K | +10.0% | -32.8% | +1.2% |
| 11/20/2023 | BV | $220K | +14.8% | +82.3% | +16.7% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
LVWR listed among consumer discretionary stocks moving in after‑market. Benzinga reported that LVWR was one of twelve consumer discretionary stocks showing price movement in Monday’s after‑market session. The activity comes as the stock is trading near its long‑term support level of $1.09, which has been tested many times. With a neutral RSI around 52, the recent movement reflects market interest but does not indicate a clear trend.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
AZTA Featured in Volatile Stock List. Azenta Inc. was included in a recent article discussing volatile stocks with promising prospects. The stock is currently trading within its 52-week range, with analysts maintaining an average price target of $37.00. This mention highlights the company's status as a high-beta asset in the current market environment.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
LAUR appears in recent education sector coverage. Recent Yahoo articles have discussed Laureate Education alongside other school operators, noting both growth opportunities and concerns about cost pressures. Some pieces highlight the stock’s potential upside, while others advise caution, noting its price under $50 and a more cautious stance. The coverage comes as the shares trade near the upper end of their 52‑week range with a trailing P/E of 16.4.
Transaction History
| BV | ▲ Buy | Grant | 2,287 | $23K | 9/30/2026 | View on chart |
| BV | ▲ Buy | Open Market | 40,000 | $450K | 8/6/2026 | View on chart |
| BV | ▲ Buy | Open Market | 10,000 | $112K | 8/6/2026 | View on chart |
| LVWR | ▼ Sell | Open Market | 216 | $486 | 7/31/2026 | View on chart |
| BV | ▲ Buy | Grant | 1,614 | $23K | 6/30/2026 | View on chart |
| LVWR | ▲ Buy | Grant | 88,029 | $0 | 5/21/2026 | View on chart |
| AZTA | ▲ Buy | Open Market | 10,000 | $164K | 5/18/2026 | View on chart |
| BV | ▲ Buy | Grant | 1,961 | $23K | 3/31/2026 | View on chart |
| BV | ▲ Buy | Option Exercise | 10,894 | — | 3/2/2026 | View on chart |
| BV | ▲ Buy | Open Market | 5,000 | $67K | 2/6/2026 | View on chart |
| BV | ▲ Buy | Grant | 1,825 | $23K | 12/31/2025 | View on chart |
| BV | ▲ Buy | Open Market | 10,000 | $128K | 12/2/2025 | View on chart |
| BV | ▲ Buy | Grant | 1,725 | $23K | 9/30/2025 | View on chart |
| BV | ▲ Buy | Grant | 1,388 | $23K | 6/30/2025 | View on chart |
| LVWR | ▼ Sell | Open Market | 25,000 | $191K | 6/10/2025 | View on chart |
| LVWR | ▼ Sell | Open Market | 15,000 | $114K | 6/10/2025 | View on chart |
| AZTA | ▲ Buy | Grant | 2,748 | $75K | 5/20/2025 | View on chart |
| AZTA | ▲ Buy | Grant | 4,152 | $112K | 5/19/2025 | View on chart |
| AZTA | ▲ Buy | Grant | 100 | $3K | 5/16/2025 | View on chart |
| LVWR | ▲ Buy | Grant | 121,360 | $0 | 5/14/2025 | View on chart |
| BV | ▲ Buy | Grant | 1,654 | $21K | 3/31/2025 | View on chart |
| BV | ▲ Buy | Option Exercise | 13,812 | — | 3/3/2025 | View on chart |
| BV | ▲ Buy | Open Market | 10,000 | $135K | 2/21/2025 | View on chart |
| BV | ▲ Buy | Grant | 1,328 | $21K | 12/31/2024 | View on chart |
| AZTA | ▲ Buy | Open Market | 12,500 | $495K | 11/18/2024 | View on chart |
| AZTA | ▼ Sell | Other | 995 | $46K | 11/6/2024 | View on chart |
| BV | ▲ Buy | Grant | 1,350 | $21K | 9/30/2024 | View on chart |
| BV | ▲ Buy | Grant | 1,597 | $21K | 6/30/2024 | View on chart |
| LVWR | ▲ Buy | Grant | 11,888 | $80K | 5/17/2024 | View on chart |
| LVWR | ▲ Buy | Grant | 18,969 | $0 | 5/16/2024 | View on chart |
| BV | ▲ Buy | Grant | 892 | $11K | 3/31/2024 | View on chart |
| BV | ▲ Buy | Option Exercise | 17,111 | — | 3/4/2024 | View on chart |
| BV | ▲ Buy | Grant | 1,261 | $11K | 12/31/2023 | View on chart |
| BV | ▲ Buy | Open Market | 20,000 | $147K | 11/20/2023 | View on chart |
| BV | ▲ Buy | Open Market | 10,000 | $73K | 11/20/2023 | View on chart |
| BV | ▲ Buy | Grant | 1,370 | $11K | 9/30/2023 | View on chart |
| BV | ▲ Buy | Grant | 1,479 | $11K | 6/30/2023 | View on chart |
| LVWR | ▲ Buy | Grant | 11,714 | $80K | 5/18/2023 | View on chart |
| LVWR | ▲ Buy | Grant | 18,302 | $0 | 5/18/2023 | View on chart |
| BV | ▲ Buy | Grant | 3,781 | $21K | 3/31/2023 | View on chart |
| BV | ▲ Buy | Option Exercise | 9,214 | — | 3/6/2023 | View on chart |
| BV | ▲ Buy | Grant | 3,084 | $21K | 12/31/2022 | View on chart |
| LVWR | ▲ Buy | Grant | 54,506 | $0 | 12/21/2022 | View on chart |
| BV | ▲ Buy | Grant | 2,676 | $21K | 9/30/2022 | View on chart |
| BV | ▲ Buy | Grant | 984 | $12K | 6/30/2022 | View on chart |
| LAUR | ▲ Buy | Grant | 9,177 | $0 | 5/25/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Morgan Stanley lowers BrightView price target to $11.5
Morgan Stanley kept its equal‑weight rating on BrightView Holdings but cut its price target to $11.5. The new target is below the stock’s recent support level of $12.68. This adjustment reflects a more cautious outlook from the firm. The change can be viewed alongside the company’s current valuation metrics.
Morgan Stanley lowers BrightView price target to $11.5. Morgan Stanley kept its equal‑weight rating on BrightView Holdings but cut its price target to $11.5. The new target is below the stock’s recent support level of $12.68. This adjustment reflects a more cautious outlook from the firm. The change can be viewed alongside the company’s current valuation metrics.